-
Catalent, Inc. (
Catalent Pharma Solutions), is an
American multinational company, and an
independent privately held
subsidiary of Novo
Holdings A/S since...
- for example,
starch and carrageenan.
Catalent Pharma Solutions is the
current owner of the
RPScherer technology.
Capsule Catalent Softgel website v t e...
- Grady-White Boats, Hyster-Yale
Materials Handling,
Thermo Fisher Scientific,
Catalent, and Avient,
among others.
Greenville is the home of East
Carolina University...
- (PDF).
October 1, 2020.
Retrieved October 29, 2020. "Etsy,
Teradyne and
Catalent Set to Join S&P 500;
Others to Join S&P
MidCap 400 and S&P
SmallCap 600"...
- In
February 2024,
parent company Novo
Holdings A/S
agreed to
acquire Catalent for $16.5 billion. On completion, Novo
Nordisk said it
would acquire three...
-
developed by
Sarepta Therapeutics,
together with Roche, and is
manufactured by
Catalent.
Delandistrogene moxeparvovec is
indicated for the
treatment of ambulatory...
-
Sarepta Therapeutics' portfolio. In
January 2023,
Sarepta partnered with
Catalent to
manufacture delandistrogene moxeparvovec (SRP-9001). In June 2023, the...
- to buy
Catalent for $16.5
billion to
expand Wegovy supply". CNBC. "Novo
Holdings closes $16.5
billion buyout of
contract manufacturer Catalent". December...
-
technology was
developed by R.P.
Scherer Corporation (currently
owned by
Catalent Pharma Solutions) in 1986. The technology's
first commercial application...
-
polystyrene sulfonate) powder". fda.gov.
Retrieved 12 July 2015. "Home –
Catalent".
catalent.com.
Retrieved 12 July 2015. "Sorbitol 70%". bttcogroup.in. Archived...
